HomeChina

China

Ex-Co-Founder of Hamster Kombat Unleashes New Game-Changing Hard Fork: Meet Hamster Cash

Beijing, China, 23rd September 2024, Chainwire

LTZ Therapeutics Raises Over $20M in Series A Financing

LTZ Therapeutics, a Redwood City, CA- and Shenzen, China-based immunotherapy-focused biotech company, closed its Series A financing of over $20m. This round, which brought...

Synthetica Pioneering Closes Series A Funding Round

Shenzhen Synthetica Pioneering Co., Ltd., a Shenzen, China-based biotech startup specializing in synthetic biology for engineering novel living bacterial therapeutics, closed a Series A funding...

Rona Therapeutics Raises $35M Series A+ Financing

Rona Therapeutics, a Shanghai, China-based clinical stage platform company which specializes in nucleic acid drug research and development, raised $35M in Series A+ funding. The...

AusperBio Raises $37M in Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company with operations in the USA and China, closed a $37m Series A financing round. The round...

Ronovo Surgical Closes $44M Series B Financing to Advance CARINA™ Platform Towards Commercialization and International Expansion

SHANGHAI and ORLANDO, June 20, 2024 – Ronovo Surgical, a Shanghai-based medical technology innovator developing novel surgical robotics for soft tissue procedures, announces the...

Gausium Raises USD50M in Series D Financing

Gausium, a Shanghai, China-based company providing autonomous cleaning solutions, raised USD50M in Series D funding. The backers were not disclosed. The company intends to use the...

Optix Raises US$15M in Funding

Optix, a Beijing, China-based XR tech startup, raised US$15M in funding. The round was led by Primavera Venture Partners. Existing investors Lanchi Ventures also participated. The...

Brise Pharmaceuticals Raises Nearly $20M in Series Pre-A and Pre-A+ Financing

Brise Pharmaceuticals Co., LTD., a Shanghai, China-based company specializing in innovative treatments for acute and chronic pain, recently completed  Pre-A and Pre-A+ financing with...

D3 Bio Receives $40M Investment from Medicxi

D3 Bio, a JiangSu and Shanghai, China-based biotechnology company, received $40M in Investment from Medicxi. The company intends to use the funds to accelerate the...

TCab Tech Raises Additional USD20M; Closes Series A Financing

TCab Tech, a Shangai, China-based eVTOL aircraft developer raised additional $20M in Series A funding. The round was led by an unnamed strategic investment fund...

Haomo Raises Over RMB 100M in Series B1 Funding

Haomo, a Beijing, China-based provider of a driver assistance system, raised over RMB 100M in Series B1 funding. Chengdu Wufa Private Equity Fund Management made...

THE DAILY NEWSLETTER - SIGNUP